AstraZeneca
The Global Development Medical Director provides medical and scientific leadership for the late-stage clinical development of respiratory and immunology products at AstraZeneca. This role involves designing, executing, and interpreting pivotal clinical trials while collaborating with global teams and external experts to support regulatory and commercial activities. The position requires expertise in pharmaceutical medicine to guide clinical programs from Phase IIb through Phase IV.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
6% below the average for this role
Global Development Medical Director, Late Respiratory and Immunology Clinical Development
American Association of Physicists in Medicine
Sr. Director - Clinical Development
Eli Lilly and Company
Clinical Research Physician - Development
Eli Lilly and Company
Senior Clinical Scientist
Alkeus Pharmaceuticals
Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL)
Celldex Therapeutics
Sr. Director - Clinical Development
Eli Lilly and Company